Aptiganel (Serbian Wikipedia)
Analysis of information sources in references of the Wikipedia article "Aptiganel" in Serbian language version.
refsWebsite
Global rank
Serbian rank
6th place
5th place
11th place
23rd place
407th place
2,473rd place
800th place
905th place
163rd place
112th place
low place
211th place
acs.org
pubs.acs.org
- Tetko IV, Tanchuk VY, Kasheva TN, Villa AE (2001). „Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”. Chem Inf. Comput. Sci. 41: 1488—1493. PMID 11749573. doi:10.1021/ci000392t.
- Ertl P.; Rohde B.; Selzer P. (2000). „Fast calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties”. J. Med. Chem. 43: 3714—3717. PMID 11020286. doi:10.1021/jm000942e.
archive.org
- Muir KW, Grosset DG, Gamzu E, Lees KR (јул 1994). „Pharmacological effects of the non-competitive NMDA antagonist CNS 1102 in normal volunteers”. British Journal of Clinical Pharmacology. 38 (1): 33—8. PMC 1364834
. PMID 7946934. doi:10.1111/j.1365-2125.1994.tb04318.x. - Schäbitz WR, Li F, Fisher M (јул 2000). „The N-methyl-D-aspartate antagonist CNS 1102 protects cerebral gray and white matter from ischemic injury following temporary focal ischemia in rats”. Stroke. 31 (7): 1709—14. PMID 10884477. doi:10.1161/01.str.31.7.1709 .
bizjournals.com
- Staff, Boston Business Journal. May 7, 1998. CNSI appoints new president, CEO
citeulike.org
- Ghose, A.K.; Viswanadhan V.N. & Wendoloski, J.J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragment Methods: An Analysis of AlogP and CLogP Methods”. J. Phys. Chem. A. 102: 3762—3772. doi:10.1021/jp980230o.
doi.org
- Reddy NL, Hu LY, Cotter RE, Fischer JB, Wong WJ, McBurney RN, et al. (јануар 1994). „Synthesis and structure-activity studies of N,N'-diarylguanidine derivatives. N-(1-naphthyl)-N'-(3-ethylphenyl)-N'-methylguanidine: a new, selective noncompetitive NMDA receptor antagonist”. Journal of Medicinal Chemistry. 37 (2): 260—7. PMID 8295213. doi:10.1021/jm00028a009.
- Muir KW, Grosset DG, Gamzu E, Lees KR (јул 1994). „Pharmacological effects of the non-competitive NMDA antagonist CNS 1102 in normal volunteers”. British Journal of Clinical Pharmacology. 38 (1): 33—8. PMC 1364834 . PMID 7946934. doi:10.1111/j.1365-2125.1994.tb04318.x.
- Schäbitz WR, Li F, Fisher M (јул 2000). „The N-methyl-D-aspartate antagonist CNS 1102 protects cerebral gray and white matter from ischemic injury following temporary focal ischemia in rats”. Stroke. 31 (7): 1709—14. PMID 10884477. doi:10.1161/01.str.31.7.1709 .
- Albers GW, Goldstein LB, Hall D, Lesko LM (децембар 2001). „Aptiganel hydrochloride in acute ischemic stroke: a randomized controlled trial”. JAMA. 286 (21): 2673—82. PMID 11730442. doi:10.1001/jama.286.21.2673.
- Muir KW, Grosset DG, Lees KR (август 1997). „Effects of prolonged infusions of the NMDA antagonist aptiganel hydrochloride (CNS 1102) in normal volunteers”. Clinical Neuropharmacology. 20 (4): 311—21. PMID 9260729. doi:10.1097/00002826-199708000-00003.
- Lees KR (новембар 1997). „Cerestat and other NMDA antagonists in ischemic stroke”. Neurology. 49 (5 Suppl 4): S66—9. PMID 9371155. S2CID 45771202. doi:10.1212/wnl.49.5_suppl_4.s66.
- Hoyte L, Barber PA, Buchan AM, Hill MD (март 2004). „The rise and fall of NMDA antagonists for ischemic stroke”. Current Molecular Medicine. 4 (2): 131—6. PMID 15032709. doi:10.2174/1566524043479248.
- Reddy NL, Hu LY, Cotter RE, Fischer JB, Wong WJ, McBurney RN, et al. (јануар 1994). „Synthesis and structure-activity studies of N,N'-diarylguanidine derivatives. N-(1-naphthyl)-N'-(3-ethylphenyl)-N'-methylguanidine: a new, selective noncompetitive NMDA receptor antagonist”. Journal of Medicinal Chemistry. 37 (2): 260—7. PMID 8295213. doi:10.1021/jm00028a009.
- Ghose, A.K.; Viswanadhan V.N. & Wendoloski, J.J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragment Methods: An Analysis of AlogP and CLogP Methods”. J. Phys. Chem. A. 102: 3762—3772. doi:10.1021/jp980230o.
- Tetko IV, Tanchuk VY, Kasheva TN, Villa AE (2001). „Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”. Chem Inf. Comput. Sci. 41: 1488—1493. PMID 11749573. doi:10.1021/ci000392t.
- Ertl P.; Rohde B.; Selzer P. (2000). „Fast calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties”. J. Med. Chem. 43: 3714—3717. PMID 11020286. doi:10.1021/jm000942e.
espacenet.com
worldwide.espacenet.com
- WO 9112797, Weber, Eckard & Keana, John F. W., "Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists", published 1991-09-05, assigned to University of Oregon and Oregon Health Sciences University; E. Weber, J. F. W. Keana, U.S. Patent 5.262.568 (1993 to State of Oregon)
google.com
- WO 9112797, Weber, Eckard & Keana, John F. W., "Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists", published 1991-09-05, assigned to University of Oregon and Oregon Health Sciences University; E. Weber, J. F. W. Keana, U.S. Patent 5.262.568 (1993 to State of Oregon)
icis.com
- Staff, ICIS. 23 May 2000 CeNeS to buy US neuroscience firm CNSI for $44m
nih.gov
ncbi.nlm.nih.gov
- Reddy NL, Hu LY, Cotter RE, Fischer JB, Wong WJ, McBurney RN, et al. (јануар 1994). „Synthesis and structure-activity studies of N,N'-diarylguanidine derivatives. N-(1-naphthyl)-N'-(3-ethylphenyl)-N'-methylguanidine: a new, selective noncompetitive NMDA receptor antagonist”. Journal of Medicinal Chemistry. 37 (2): 260—7. PMID 8295213. doi:10.1021/jm00028a009.
- Muir KW, Grosset DG, Gamzu E, Lees KR (јул 1994). „Pharmacological effects of the non-competitive NMDA antagonist CNS 1102 in normal volunteers”. British Journal of Clinical Pharmacology. 38 (1): 33—8. PMC 1364834 . PMID 7946934. doi:10.1111/j.1365-2125.1994.tb04318.x.
- Schäbitz WR, Li F, Fisher M (јул 2000). „The N-methyl-D-aspartate antagonist CNS 1102 protects cerebral gray and white matter from ischemic injury following temporary focal ischemia in rats”. Stroke. 31 (7): 1709—14. PMID 10884477. doi:10.1161/01.str.31.7.1709 .
- Albers GW, Goldstein LB, Hall D, Lesko LM (децембар 2001). „Aptiganel hydrochloride in acute ischemic stroke: a randomized controlled trial”. JAMA. 286 (21): 2673—82. PMID 11730442. doi:10.1001/jama.286.21.2673.
- Muir KW, Grosset DG, Lees KR (август 1997). „Effects of prolonged infusions of the NMDA antagonist aptiganel hydrochloride (CNS 1102) in normal volunteers”. Clinical Neuropharmacology. 20 (4): 311—21. PMID 9260729. doi:10.1097/00002826-199708000-00003.
- Lees KR (новембар 1997). „Cerestat and other NMDA antagonists in ischemic stroke”. Neurology. 49 (5 Suppl 4): S66—9. PMID 9371155. S2CID 45771202. doi:10.1212/wnl.49.5_suppl_4.s66.
- Hoyte L, Barber PA, Buchan AM, Hill MD (март 2004). „The rise and fall of NMDA antagonists for ischemic stroke”. Current Molecular Medicine. 4 (2): 131—6. PMID 15032709. doi:10.2174/1566524043479248.
- Reddy NL, Hu LY, Cotter RE, Fischer JB, Wong WJ, McBurney RN, et al. (јануар 1994). „Synthesis and structure-activity studies of N,N'-diarylguanidine derivatives. N-(1-naphthyl)-N'-(3-ethylphenyl)-N'-methylguanidine: a new, selective noncompetitive NMDA receptor antagonist”. Journal of Medicinal Chemistry. 37 (2): 260—7. PMID 8295213. doi:10.1021/jm00028a009.
- Tetko IV, Tanchuk VY, Kasheva TN, Villa AE (2001). „Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”. Chem Inf. Comput. Sci. 41: 1488—1493. PMID 11749573. doi:10.1021/ci000392t.
- Ertl P.; Rohde B.; Selzer P. (2000). „Fast calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties”. J. Med. Chem. 43: 3714—3717. PMID 11020286. doi:10.1021/jm000942e.